AbbVie (ABBV) Shares Outstanding (Diluted Average) (2012 - 2026)

AbbVie (ABBV) has 15 years of Shares Outstanding (Diluted Average) data on file, last reported at $1.8 billion in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $1.8 billion, changed 0.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 billion (changed 0.11% YoY), and the FY2025 annual result was $1.8 billion, changed 0.0% from the prior year.
• Shares Outstanding (Diluted Average) steadied at $1.8 billion in Q1 2026 per ABBV's latest filing, from $1.8 billion in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $1.8 billion in Q1 2022 and troughed at $1.8 billion in Q3 2023.
• A 5-year average of $1.8 billion and a median of $1.8 billion in 2023 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) rose 0.17% in 2022, then declined 0.28% in 2023.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $1.8 billion in 2022, then fell by 0.28% to $1.8 billion in 2023, then changed by 0.0% to $1.8 billion in 2024, then changed by 0.0% to $1.8 billion in 2025, then gained by 0.06% to $1.8 billion in 2026.
• Business Quant data shows ABBV's Shares Outstanding (Diluted Average) at $1.8 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.8 billion in Q3 2025.